Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Evoked Retinal Response

Not Applicable

Terminated

Conditions: Retinitis Pigmentosa

Interventions: Procedure: Ultrasound Stimulus

First Posted Date: 2011-08-12

Last Posted Date: 2013-04-05

Lead Sponsor: Columbia University

Target Recruit Count: 1

Registration Number: NCT01415453

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Annular Array Ultrasound in Ophthalmology

Completed

Conditions: Diabetic Retinopathy
Posterior Vitreous Detachment

Interventions: Procedure: annular array ultrasound exam

First Posted Date: 2011-08-11

Last Posted Date: 2019-01-30

Lead Sponsor: Columbia University

Target Recruit Count: 30

Registration Number: NCT01415037

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Cook for Your Life!: Implementing Dietary Change Among Hispanic Breast Cancer Survivors

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Written dietary recommendations
Behavioral: Cocinar Para Su Salud Program

First Posted Date: 2011-08-11

Last Posted Date: 2024-08-23

Lead Sponsor: Columbia University

Target Recruit Count: 82

Registration Number: NCT01414062

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant

Completed

Conditions: Cardiac Allograft Vasculopathy

First Posted Date: 2011-07-27

Last Posted Date: 2017-08-31

Lead Sponsor: Columbia University

Target Recruit Count: 60

Registration Number: NCT01403142

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Keratoconus Detection by Ultrasound

Completed

Conditions: Keratoconus

Interventions: Procedure: Artemis Ultrasound Exam
Procedure: Optical Coherence Tomography (OCT) Exam

First Posted Date: 2011-07-27

Last Posted Date: 2021-08-03

Lead Sponsor: Columbia University

Target Recruit Count: 250

Registration Number: NCT01403129

Locations: 🇬🇧
London Vision Clinic, London, England, United Kingdom
🇺🇸
Columbia University Medical Center, New York, New York, United States

Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary

Completed

Conditions: Chronic Obstructive Pulmonary Disease

First Posted Date: 2011-07-20

Last Posted Date: 2024-07-24

Lead Sponsor: Columbia University

Target Recruit Count: 359

Registration Number: NCT01397721

Locations: 🇺🇸
Columbia University, New York, New York, United States
🇺🇸
UCLA Research Center, Alhambra, California, United States
🇺🇸
Northwestern University Medical School, Chicago, Illinois, United States

and more 1 locations

Effect of Cabergoline on Weight and Glucose Tolerance

Phase 1

Completed

Conditions: Body Weight
Impaired Glucose Tolerance in Obese

Interventions: Other: placebo
Drug: Cabergoline

First Posted Date: 2011-07-15

Last Posted Date: 2015-10-14

Lead Sponsor: Columbia University

Target Recruit Count: 40

Registration Number: NCT01395602

Locations: 🇺🇸
Columbia University, New York, New York, United States

Connect 'n Unite: Couples-Based HIV/STI Prevention for Drug-Involved, Black MSM

Not Applicable

Completed

Conditions: HIV
Sexually Transmitted Infections

Interventions: Behavioral: CNU Intervention
Behavioral: WP Intervention

First Posted Date: 2011-07-15

Last Posted Date: 2024-06-04

Lead Sponsor: Columbia University

Target Recruit Count: 424

Registration Number: NCT01394900

Locations: 🇺🇸
Columbia University School of Social Work, New York, New York, United States

Prognosis of Very Low Dose SPECT

Completed

Conditions: Chest Pain

First Posted Date: 2011-07-04

Last Posted Date: 2015-02-04

Lead Sponsor: Columbia University

Target Recruit Count: 100

Registration Number: NCT01387152

Locations: 🇺🇸
New York Presbyterian Hospital- Columbia University Medical Center, New York, New York, United States

Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: Lenalidomide
Drug: Docetaxel
Drug: Prednisone

First Posted Date: 2011-06-22

Last Posted Date: 2016-05-09

Lead Sponsor: Columbia University

Target Recruit Count: 64

Registration Number: NCT01378091

Locations: 🇺🇸
Cornell Weill Medical Center, New York, New York, United States
🇺🇸
Columbia University Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy